Global Vaginal Fungi Infections Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 08 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Vaginal candidiasis is usually treated with antifungal medicine. For most infections, the treatment is an antifungal medicine applied inside the vagina or a single dose of fluconazole taken by mouth.

According to our (Global Info Research) latest study, the global Vaginal Fungi Infections Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Vaginal Fungi Infections Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Vaginal Fungi Infections Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Vaginal Fungi Infections Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Vaginal Fungi Infections Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Vaginal Fungi Infections Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vaginal Fungi Infections Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vaginal Fungi Infections Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Hikma Pharmaceuticals Plc and Lupin Limited, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Vaginal Fungi Infections Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Fluconazole
    Nystatin
    Flucytosine
    Others

Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Market segment by players, this report covers
    Pfizer Inc.
    Bausch Health Companies Inc
    ANI Pharmaceuticals
    Hikma Pharmaceuticals Plc
    Lupin Limited
    Mycovia Pharmaceuticals
    Glenmark Pharmaceuticals Limited
    Unique Pharmaceuticals
    PEPTONIC medical AB
    Aurobindo Pharma Limited
    Dr. Reddy's Laboratories
    SCYNEXIS

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Vaginal Fungi Infections Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Vaginal Fungi Infections Treatment, with revenue, gross margin and global market share of Vaginal Fungi Infections Treatment from 2018 to 2023.
Chapter 3, the Vaginal Fungi Infections Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Vaginal Fungi Infections Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Vaginal Fungi Infections Treatment.
Chapter 13, to describe Vaginal Fungi Infections Treatment research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Vaginal Fungi Infections Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Vaginal Fungi Infections Treatment by Type
        1.3.1 Overview: Global Vaginal Fungi Infections Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Vaginal Fungi Infections Treatment Consumption Value Market Share by Type in 2022
        1.3.3 Fluconazole
        1.3.4 Nystatin
        1.3.5 Flucytosine
        1.3.6 Others
    1.4 Global Vaginal Fungi Infections Treatment Market by Application
        1.4.1 Overview: Global Vaginal Fungi Infections Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
    1.5 Global Vaginal Fungi Infections Treatment Market Size & Forecast
    1.6 Global Vaginal Fungi Infections Treatment Market Size and Forecast by Region
        1.6.1 Global Vaginal Fungi Infections Treatment Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Vaginal Fungi Infections Treatment Market Size by Region, (2018-2029)
        1.6.3 North America Vaginal Fungi Infections Treatment Market Size and Prospect (2018-2029)
        1.6.4 Europe Vaginal Fungi Infections Treatment Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Vaginal Fungi Infections Treatment Market Size and Prospect (2018-2029)
        1.6.6 South America Vaginal Fungi Infections Treatment Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Vaginal Fungi Infections Treatment Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Pfizer Inc.
        2.1.1 Pfizer Inc. Details
        2.1.2 Pfizer Inc. Major Business
        2.1.3 Pfizer Inc. Vaginal Fungi Infections Treatment Product and Solutions
        2.1.4 Pfizer Inc. Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Inc. Recent Developments and Future Plans
    2.2 Bausch Health Companies Inc
        2.2.1 Bausch Health Companies Inc Details
        2.2.2 Bausch Health Companies Inc Major Business
        2.2.3 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product and Solutions
        2.2.4 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bausch Health Companies Inc Recent Developments and Future Plans
    2.3 ANI Pharmaceuticals
        2.3.1 ANI Pharmaceuticals Details
        2.3.2 ANI Pharmaceuticals Major Business
        2.3.3 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions
        2.3.4 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 ANI Pharmaceuticals Recent Developments and Future Plans
    2.4 Hikma Pharmaceuticals Plc
        2.4.1 Hikma Pharmaceuticals Plc Details
        2.4.2 Hikma Pharmaceuticals Plc Major Business
        2.4.3 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product and Solutions
        2.4.4 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Hikma Pharmaceuticals Plc Recent Developments and Future Plans
    2.5 Lupin Limited
        2.5.1 Lupin Limited Details
        2.5.2 Lupin Limited Major Business
        2.5.3 Lupin Limited Vaginal Fungi Infections Treatment Product and Solutions
        2.5.4 Lupin Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Lupin Limited Recent Developments and Future Plans
    2.6 Mycovia Pharmaceuticals
        2.6.1 Mycovia Pharmaceuticals Details
        2.6.2 Mycovia Pharmaceuticals Major Business
        2.6.3 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions
        2.6.4 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Mycovia Pharmaceuticals Recent Developments and Future Plans
    2.7 Glenmark Pharmaceuticals Limited
        2.7.1 Glenmark Pharmaceuticals Limited Details
        2.7.2 Glenmark Pharmaceuticals Limited Major Business
        2.7.3 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product and Solutions
        2.7.4 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Glenmark Pharmaceuticals Limited Recent Developments and Future Plans
    2.8 Unique Pharmaceuticals
        2.8.1 Unique Pharmaceuticals Details
        2.8.2 Unique Pharmaceuticals Major Business
        2.8.3 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions
        2.8.4 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Unique Pharmaceuticals Recent Developments and Future Plans
    2.9 PEPTONIC medical AB
        2.9.1 PEPTONIC medical AB Details
        2.9.2 PEPTONIC medical AB Major Business
        2.9.3 PEPTONIC medical AB Vaginal Fungi Infections Treatment Product and Solutions
        2.9.4 PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 PEPTONIC medical AB Recent Developments and Future Plans
    2.10 Aurobindo Pharma Limited
        2.10.1 Aurobindo Pharma Limited Details
        2.10.2 Aurobindo Pharma Limited Major Business
        2.10.3 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product and Solutions
        2.10.4 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Aurobindo Pharma Limited Recent Developments and Future Plans
    2.11 Dr. Reddy's Laboratories
        2.11.1 Dr. Reddy's Laboratories Details
        2.11.2 Dr. Reddy's Laboratories Major Business
        2.11.3 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product and Solutions
        2.11.4 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Dr. Reddy's Laboratories Recent Developments and Future Plans
    2.12 SCYNEXIS
        2.12.1 SCYNEXIS Details
        2.12.2 SCYNEXIS Major Business
        2.12.3 SCYNEXIS Vaginal Fungi Infections Treatment Product and Solutions
        2.12.4 SCYNEXIS Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 SCYNEXIS Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Vaginal Fungi Infections Treatment Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Vaginal Fungi Infections Treatment by Company Revenue
        3.2.2 Top 3 Vaginal Fungi Infections Treatment Players Market Share in 2022
        3.2.3 Top 6 Vaginal Fungi Infections Treatment Players Market Share in 2022
    3.3 Vaginal Fungi Infections Treatment Market: Overall Company Footprint Analysis
        3.3.1 Vaginal Fungi Infections Treatment Market: Region Footprint
        3.3.2 Vaginal Fungi Infections Treatment Market: Company Product Type Footprint
        3.3.3 Vaginal Fungi Infections Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Vaginal Fungi Infections Treatment Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Vaginal Fungi Infections Treatment Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Vaginal Fungi Infections Treatment Consumption Value Market Share by Application (2018-2023)
    5.2 Global Vaginal Fungi Infections Treatment Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2029)
    6.2 North America Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2029)
    6.3 North America Vaginal Fungi Infections Treatment Market Size by Country
        6.3.1 North America Vaginal Fungi Infections Treatment Consumption Value by Country (2018-2029)
        6.3.2 United States Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        6.3.3 Canada Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        6.3.4 Mexico Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2029)
    7.2 Europe Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2029)
    7.3 Europe Vaginal Fungi Infections Treatment Market Size by Country
        7.3.1 Europe Vaginal Fungi Infections Treatment Consumption Value by Country (2018-2029)
        7.3.2 Germany Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        7.3.3 France Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        7.3.5 Russia Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        7.3.6 Italy Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Region
        8.3.1 Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value by Region (2018-2029)
        8.3.2 China Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        8.3.3 Japan Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        8.3.4 South Korea Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        8.3.5 India Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        8.3.7 Australia Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2029)
    9.2 South America Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2029)
    9.3 South America Vaginal Fungi Infections Treatment Market Size by Country
        9.3.1 South America Vaginal Fungi Infections Treatment Consumption Value by Country (2018-2029)
        9.3.2 Brazil Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        9.3.3 Argentina Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country
        10.3.1 Middle East & Africa Vaginal Fungi Infections Treatment Consumption Value by Country (2018-2029)
        10.3.2 Turkey Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)
        10.3.4 UAE Vaginal Fungi Infections Treatment Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Vaginal Fungi Infections Treatment Market Drivers
    11.2 Vaginal Fungi Infections Treatment Market Restraints
    11.3 Vaginal Fungi Infections Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Vaginal Fungi Infections Treatment Industry Chain
    12.2 Vaginal Fungi Infections Treatment Upstream Analysis
    12.3 Vaginal Fungi Infections Treatment Midstream Analysis
    12.4 Vaginal Fungi Infections Treatment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Vaginal Fungi Infections Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Vaginal Fungi Infections Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Vaginal Fungi Infections Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Vaginal Fungi Infections Treatment Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Pfizer Inc. Company Information, Head Office, and Major Competitors
    Table 6. Pfizer Inc. Major Business
    Table 7. Pfizer Inc. Vaginal Fungi Infections Treatment Product and Solutions
    Table 8. Pfizer Inc. Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Pfizer Inc. Recent Developments and Future Plans
    Table 10. Bausch Health Companies Inc Company Information, Head Office, and Major Competitors
    Table 11. Bausch Health Companies Inc Major Business
    Table 12. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product and Solutions
    Table 13. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Bausch Health Companies Inc Recent Developments and Future Plans
    Table 15. ANI Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 16. ANI Pharmaceuticals Major Business
    Table 17. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions
    Table 18. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. ANI Pharmaceuticals Recent Developments and Future Plans
    Table 20. Hikma Pharmaceuticals Plc Company Information, Head Office, and Major Competitors
    Table 21. Hikma Pharmaceuticals Plc Major Business
    Table 22. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product and Solutions
    Table 23. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Hikma Pharmaceuticals Plc Recent Developments and Future Plans
    Table 25. Lupin Limited Company Information, Head Office, and Major Competitors
    Table 26. Lupin Limited Major Business
    Table 27. Lupin Limited Vaginal Fungi Infections Treatment Product and Solutions
    Table 28. Lupin Limited Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Lupin Limited Recent Developments and Future Plans
    Table 30. Mycovia Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 31. Mycovia Pharmaceuticals Major Business
    Table 32. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions
    Table 33. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Mycovia Pharmaceuticals Recent Developments and Future Plans
    Table 35. Glenmark Pharmaceuticals Limited Company Information, Head Office, and Major Competitors
    Table 36. Glenmark Pharmaceuticals Limited Major Business
    Table 37. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product and Solutions
    Table 38. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Glenmark Pharmaceuticals Limited Recent Developments and Future Plans
    Table 40. Unique Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 41. Unique Pharmaceuticals Major Business
    Table 42. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product and Solutions
    Table 43. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Unique Pharmaceuticals Recent Developments and Future Plans
    Table 45. PEPTONIC medical AB Company Information, Head Office, and Major Competitors
    Table 46. PEPTONIC medical AB Major Business
    Table 47. PEPTONIC medical AB Vaginal Fungi Infections Treatment Product and Solutions
    Table 48. PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. PEPTONIC medical AB Recent Developments and Future Plans
    Table 50. Aurobindo Pharma Limited Company Information, Head Office, and Major Competitors
    Table 51. Aurobindo Pharma Limited Major Business
    Table 52. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product and Solutions
    Table 53. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Aurobindo Pharma Limited Recent Developments and Future Plans
    Table 55. Dr. Reddy's Laboratories Company Information, Head Office, and Major Competitors
    Table 56. Dr. Reddy's Laboratories Major Business
    Table 57. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product and Solutions
    Table 58. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Dr. Reddy's Laboratories Recent Developments and Future Plans
    Table 60. SCYNEXIS Company Information, Head Office, and Major Competitors
    Table 61. SCYNEXIS Major Business
    Table 62. SCYNEXIS Vaginal Fungi Infections Treatment Product and Solutions
    Table 63. SCYNEXIS Vaginal Fungi Infections Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. SCYNEXIS Recent Developments and Future Plans
    Table 65. Global Vaginal Fungi Infections Treatment Revenue (USD Million) by Players (2018-2023)
    Table 66. Global Vaginal Fungi Infections Treatment Revenue Share by Players (2018-2023)
    Table 67. Breakdown of Vaginal Fungi Infections Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 68. Market Position of Players in Vaginal Fungi Infections Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 69. Head Office of Key Vaginal Fungi Infections Treatment Players
    Table 70. Vaginal Fungi Infections Treatment Market: Company Product Type Footprint
    Table 71. Vaginal Fungi Infections Treatment Market: Company Product Application Footprint
    Table 72. Vaginal Fungi Infections Treatment New Market Entrants and Barriers to Market Entry
    Table 73. Vaginal Fungi Infections Treatment Mergers, Acquisition, Agreements, and Collaborations
    Table 74. Global Vaginal Fungi Infections Treatment Consumption Value (USD Million) by Type (2018-2023)
    Table 75. Global Vaginal Fungi Infections Treatment Consumption Value Share by Type (2018-2023)
    Table 76. Global Vaginal Fungi Infections Treatment Consumption Value Forecast by Type (2024-2029)
    Table 77. Global Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2023)
    Table 78. Global Vaginal Fungi Infections Treatment Consumption Value Forecast by Application (2024-2029)
    Table 79. North America Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 80. North America Vaginal Fungi Infections Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 81. North America Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 82. North America Vaginal Fungi Infections Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 83. North America Vaginal Fungi Infections Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 84. North America Vaginal Fungi Infections Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 85. Europe Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 86. Europe Vaginal Fungi Infections Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 87. Europe Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 88. Europe Vaginal Fungi Infections Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 89. Europe Vaginal Fungi Infections Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 90. Europe Vaginal Fungi Infections Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 91. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 92. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 93. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 94. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 95. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value by Region (2018-2023) & (USD Million)
    Table 96. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value by Region (2024-2029) & (USD Million)
    Table 97. South America Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 98. South America Vaginal Fungi Infections Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 99. South America Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 100. South America Vaginal Fungi Infections Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 101. South America Vaginal Fungi Infections Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 102. South America Vaginal Fungi Infections Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 103. Middle East & Africa Vaginal Fungi Infections Treatment Consumption Value by Type (2018-2023) & (USD Million)
    Table 104. Middle East & Africa Vaginal Fungi Infections Treatment Consumption Value by Type (2024-2029) & (USD Million)
    Table 105. Middle East & Africa Vaginal Fungi Infections Treatment Consumption Value by Application (2018-2023) & (USD Million)
    Table 106. Middle East & Africa Vaginal Fungi Infections Treatment Consumption Value by Application (2024-2029) & (USD Million)
    Table 107. Middle East & Africa Vaginal Fungi Infections Treatment Consumption Value by Country (2018-2023) & (USD Million)
    Table 108. Middle East & Africa Vaginal Fungi Infections Treatment Consumption Value by Country (2024-2029) & (USD Million)
    Table 109. Vaginal Fungi Infections Treatment Raw Material
    Table 110. Key Suppliers of Vaginal Fungi Infections Treatment Raw Materials
List of Figures
    Figure 1. Vaginal Fungi Infections Treatment Picture
    Figure 2. Global Vaginal Fungi Infections Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Vaginal Fungi Infections Treatment Consumption Value Market Share by Type in 2022
    Figure 4. Fluconazole
    Figure 5. Nystatin
    Figure 6. Flucytosine
    Figure 7. Others
    Figure 8. Global Vaginal Fungi Infections Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Vaginal Fungi Infections Treatment Consumption Value Market Share by Application in 2022
    Figure 10. Hospital Pharmacies Picture
    Figure 11. Retail Pharmacies Picture
    Figure 12. Online Pharmacies Picture
    Figure 13. Global Vaginal Fungi Infections Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Vaginal Fungi Infections Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Vaginal Fungi Infections Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Vaginal Fungi Infections Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Vaginal Fungi Infections Treatment Consumption Value Market Share by Region in 2022
    Figure 18. North America Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Vaginal Fungi Infections Treatment Revenue Share by Players in 2022
    Figure 24. Vaginal Fungi Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Vaginal Fungi Infections Treatment Market Share in 2022
    Figure 26. Global Top 6 Players Vaginal Fungi Infections Treatment Market Share in 2022
    Figure 27. Global Vaginal Fungi Infections Treatment Consumption Value Share by Type (2018-2023)
    Figure 28. Global Vaginal Fungi Infections Treatment Market Share Forecast by Type (2024-2029)
    Figure 29. Global Vaginal Fungi Infections Treatment Consumption Value Share by Application (2018-2023)
    Figure 30. Global Vaginal Fungi Infections Treatment Market Share Forecast by Application (2024-2029)
    Figure 31. North America Vaginal Fungi Infections Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Vaginal Fungi Infections Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Vaginal Fungi Infections Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Vaginal Fungi Infections Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Vaginal Fungi Infections Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Vaginal Fungi Infections Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Vaginal Fungi Infections Treatment Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Vaginal Fungi Infections Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Vaginal Fungi Infections Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Vaginal Fungi Infections Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Vaginal Fungi Infections Treatment Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Vaginal Fungi Infections Treatment Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Vaginal Fungi Infections Treatment Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Vaginal Fungi Infections Treatment Consumption Value (2018-2029) & (USD Million)
    Figure 65. Vaginal Fungi Infections Treatment Market Drivers
    Figure 66. Vaginal Fungi Infections Treatment Market Restraints
    Figure 67. Vaginal Fungi Infections Treatment Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Vaginal Fungi Infections Treatment in 2022
    Figure 70. Manufacturing Process Analysis of Vaginal Fungi Infections Treatment
    Figure 71. Vaginal Fungi Infections Treatment Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer Inc.
Bausch Health Companies Inc
ANI Pharmaceuticals
Hikma Pharmaceuticals Plc
Lupin Limited
Mycovia Pharmaceuticals
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC medical AB
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
SCYNEXIS

Related Reports

Global Vaginal Fungi Infections Treatment Supply, Demand and Key Producers, 2023-2029

Global Vaginal Fungi Infections Treatment Supply, Demand and Key Producers, 2023-2029

date 20 Feb 2023

date Pharma & Healthcare

The global Vaginal Fungi Infections Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Vaginal Fungi Infections Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Vaginal Fungi Infections Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 12 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Vaginal Fungi Infections Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Vaginal Fungi Infections Treatment Supply, Demand and Key Producers, 2024-2030

Global Vaginal Fungi Infections Treatment Supply, Demand and Key Producers, 2024-2030

date 14 Feb 2024

date Pharma & Healthcare

The global Vaginal Fungi Infections Treatment market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Vaginal Fungi Infections Treatment

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>